Seqens

Highly Engaged Employees

Seqens, established in 2003, is a prominent pharmaceutical manufacturing company specializing in fractionated blood products for the life sciences and in-vitro diagnostics industries. The company offers a comprehensive portfolio of biological materials, including bovine serum albumin, bovine fibrinogen, human plasma, and processed sera. With operations across North America, Europe, and Asia-Pacific, Seqens serves global healthcare and scientific research sectors with specialized pharmaceutical ingredients and biological components essential for diagnostic testing, research, and therapeutic development.

This specialized range is vital for diagnostic testing, advanced research, and therapeutic development. Seqens operates with a significant workforce, employing between 1,000 and 5,000 individuals, and maintains a robust presence across 12 locations worldwide. This scale enables efficient delivery of specialized pharmaceutical ingredients and biological components. For insights into the individuals driving these operations and innovations, one can explore Meet Seqens's team. Their commitment to quality and specialized manufacturing underpins their role in advancing medical and scientific frontiers.

Seqens generates substantial revenue, reported at $1.1B, underscoring its market significance. The company's focus on high-quality, specialized pharmaceutical ingredients and biological components makes it an indispensable partner for global healthcare providers and research institutions. By concentrating on niche areas like fractionated blood products, Seqens carves out a distinct market position, contributing to the development of new diagnostics and treatments. Its operations meet stringent demands, ensuring critical material availability for innovation and patient care.